Qing Jin

1.8k total citations
32 papers, 1.6k citations indexed

About

Qing Jin is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Qing Jin has authored 32 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Organic Chemistry, 18 papers in Molecular Biology and 4 papers in Infectious Diseases. Recurrent topics in Qing Jin's work include Carbohydrate Chemistry and Synthesis (9 papers), Chemical Synthesis and Analysis (9 papers) and Cancer therapeutics and mechanisms (7 papers). Qing Jin is often cited by papers focused on Carbohydrate Chemistry and Synthesis (9 papers), Chemical Synthesis and Analysis (9 papers) and Cancer therapeutics and mechanisms (7 papers). Qing Jin collaborates with scholars based in United States, China and Japan. Qing Jin's co-authors include Dale L. Boger, Christopher W. Boyce, Marc Labroli, Clark A. Sehon, Michael P. Hedrick, Steven L. Castle, Susumu Miyazaki, Jason H. Wu, Olivier Loiseleur and Mark Searcey and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Qing Jin

32 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qing Jin United States 22 1.1k 682 300 133 97 32 1.6k
Douglas A. Horton Australia 6 2.7k 2.3× 872 1.3× 347 1.2× 83 0.6× 75 0.8× 10 3.0k
Olivier Provot France 34 2.5k 2.2× 570 0.8× 195 0.7× 82 0.6× 136 1.4× 111 2.8k
Yves Génisson France 25 1.6k 1.4× 693 1.0× 175 0.6× 73 0.5× 39 0.4× 91 2.0k
Wayne K. Anderson United States 20 945 0.8× 433 0.6× 82 0.3× 61 0.5× 68 0.7× 77 1.3k
Jean‐Yves Mérour France 26 2.0k 1.7× 775 1.1× 112 0.4× 83 0.6× 150 1.5× 98 2.3k
A. M. VAN LEUSEN Netherlands 28 2.2k 2.0× 619 0.9× 118 0.4× 168 1.3× 48 0.5× 114 2.6k
Daniel Yohannes United States 25 1.1k 1.0× 805 1.2× 284 0.9× 33 0.2× 50 0.5× 48 1.6k
Steven Nahm United States 8 1.5k 1.3× 636 0.9× 149 0.5× 44 0.3× 24 0.2× 10 1.8k
Yagamare Fall Spain 21 827 0.7× 382 0.6× 131 0.4× 68 0.5× 24 0.2× 121 1.4k
Jörg‐Martin Neudörfl Germany 23 956 0.8× 641 0.9× 159 0.5× 130 1.0× 24 0.2× 82 1.6k

Countries citing papers authored by Qing Jin

Since Specialization
Citations

This map shows the geographic impact of Qing Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Jin more than expected).

Fields of papers citing papers by Qing Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Jin. The network helps show where Qing Jin may publish in the future.

Co-authorship network of co-authors of Qing Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Qing Jin. A scholar is included among the top collaborators of Qing Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing Jin. Qing Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
McAtee, J. Jeffrey, Steven L. Castle, Qing Jin, & Dale L. Boger. (2002). Synthesis and evaluation of vancomycin and vancomycin aglycon analogues that bear modifications in the residue 3 asparagine. Bioorganic & Medicinal Chemistry Letters. 12(9). 1319–1322. 21 indexed citations
3.
Marsilje, Thomas H., Marc Labroli, Michael P. Hedrick, et al.. (2002). 10-Formyl-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid (10-Formyl-DDACTHF). Bioorganic & Medicinal Chemistry. 10(8). 2739–2749. 13 indexed citations
5.
Boger, Dale L., Marc Labroli, Thomas H. Marsilje, et al.. (2000). Conformationally restricted analogues designed for selective inhibition of GAR Tfase versus thymidylate synthase or dihydrofolate reductase. Bioorganic & Medicinal Chemistry. 8(5). 1075–1086. 15 indexed citations
7.
Boger, Dale L., Mark Searcey, Winston C. Tse, & Qing Jin. (2000). Bifunctional alkylating agents derived from duocarmycin SA: potent antitumor activity with altered sequence selectivity. Bioorganic & Medicinal Chemistry Letters. 10(5). 495–498. 7 indexed citations
8.
Boger, Dale L., et al.. (2000). ChemInform Abstract: Total Synthesis and Comparative Evaluation of Luzopeptin A—C and Quinoxapeptin A—C.. ChemInform. 31(10). 1 indexed citations
9.
Boger, Dale L., D. R. Soenen, Christopher W. Boyce, Michael P. Hedrick, & Qing Jin. (2000). Total Synthesis of Ningalin B Utilizing a Heterocyclic Azadiene Diels−Alder Reaction and Discovery of a New Class of Potent Multidrug Resistant (MDR) Reversal Agents. The Journal of Organic Chemistry. 65(8). 2479–2483. 125 indexed citations
11.
Boger, Dale L., Susumu Miyazaki, Seong Heon Kim, et al.. (1999). Total Synthesis of the Vancomycin Aglycon. Journal of the American Chemical Society. 121(43). 10004–10011. 164 indexed citations
12.
Boger, Dale L., et al.. (1999). Totalsynthese von Chinoxapeptin A–C: Bestimmung der absoluten Konfiguration. Angewandte Chemie. 111(16). 2533–2536. 7 indexed citations
13.
Boger, Dale L., Alejandro Santillán, Mark Searcey, & Qing Jin. (1999). Synthesis and Evaluation of Duocarmycin and CC-1065 Analogues Containing Modifications in the Subunit Linking Amide. The Journal of Organic Chemistry. 64(14). 5241–5244. 21 indexed citations
14.
Boger, Dale L., et al.. (1998). Synthesis of key sandramycin analogs: systematic examination of the intercalation chromophore. Bioorganic & Medicinal Chemistry. 6(1). 85–102. 29 indexed citations
15.
Boger, Dale L., Jean E. Patterson, & Qing Jin. (1998). Structural requirements for 5-HT 2A and 5-HT 1A serotonin receptor potentiation by the biologically active lipid oleamide. Proceedings of the National Academy of Sciences. 95(8). 4102–4107. 81 indexed citations
16.
Boger, Dale L., Alejandro Santillán, Mark Searcey, & Qing Jin. (1998). Critical Role of the Linking Amide in CC-1065 and the Duocarmycins:  Implications on the Source of DNA Alkylation Catalysis. Journal of the American Chemical Society. 120(45). 11554–11557. 41 indexed citations
17.
Boger, Dale L., Christopher W. Boyce, Marc Labroli, Clark A. Sehon, & Qing Jin. (1998). Total Syntheses of Ningalin A, Lamellarin O, Lukianol A, and Permethyl Storniamide A Utilizing Heterocyclic Azadiene Diels−Alder Reactions. Journal of the American Chemical Society. 121(1). 54–62. 350 indexed citations
18.
Boger, Dale L., Donald L. Hertzog, Douglas S. Johnson, et al.. (1997). Reversed and Sandwiched Analogs of Duocarmycin SA:  Establishment of the Origin of the Sequence-Selective Alkylation of DNA and New Insights into the Source of Catalysis. Journal of the American Chemical Society. 119(21). 4987–4998. 61 indexed citations
19.
Boger, Dale L., Michael A. Patane, Qing Jin, & Paul A. Kitos. (1994). Design, synthesis and evaluation of bouvardin, deoxybouvardin and RA-I-XIV pharmacophore analogs. Bioorganic & Medicinal Chemistry. 2(2). 85–100. 15 indexed citations
20.
Boger, Dale L., Weiya Yun, Shiro Terashima, et al.. (1992). DNA alkylation properties of the duocarmycins: (+)-duocarmycin A, epi-(+)-duocarmycin A, ent-(−)-duocarmycin A and epi,ent-(−)-duocarmycin A. Bioorganic & Medicinal Chemistry Letters. 2(7). 759–765. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026